Voxelotor
Back to searchMolecule Structure
Scientific Name
Voxelotor
Description of the Drug
Voxelotor is a drug used to inhibit the polymerization of hemoglobin S, preventing the painful and sometimes lethal vaso-occlusive crises associated with sickle cell disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14975
http://www.drugbank.ca/drugs/DB14975
Brand Name(s)
Oxbryta
Company Owner(s)
Global Blood Therapeutics Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Hemoglobin HbA | PROTEIN COMPLEX | POSITIVE MODULATOR | CHEMBL2095168 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL15065529 | |
| Human Metabolome Database | HMDB0304877 | |
| DrugBank | DB14975 | |
| PubChem: Thomson Pharma | 163684003 | |
| PubChem | 71602803 | |
| BindingDB | 50235297 | |
| DrugCentral | 5356 | |
| ChemicalBook | CB73053893 | |
| Guide to Pharmacology | 10559 | |
| rxnorm | OXBRYTA | VOXELOTOR |
| ZINC | ZINC000145969085 |
